rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Xiaobin Wu

President and COO

Company insider

Files Form 4 as: President and COO, BeOne Medicines.

Every Form 4 they filed

In numbers

Trades disclosed
202
Buys
0
Sells
53
Bought
$0
Sold
$106.2M
Companies
1
Companies where not an officer
0
First trade
30 Apr 2018
Last trade
25 Aug 2026
Last filed
27 Aug 2026

Companies traded

Where they are an officer
ONC BeOne MedicinesOfficer · Biotechnology · last 25 Aug 20260 buys · 53 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
40Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
25 Aug 2026filed 27 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$106K280 at $380.00filing
25 Aug 2026filed 27 Aug 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$106K280 at $380.00filing
23 Jun 2026filed 25 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$357K1,292 at $276.26filing
23 Jun 2026filed 25 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$357K1,292 at $276.26filing
16 Jun 2026filed 18 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$362K1,357 at $266.76filing
16 Jun 2026filed 18 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$362K1,357 at $266.76filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—118,625 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$164K626 at $261.20filing
11 Jun 2026filed 15 Jun 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—229,775 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne Medicinesoption or derivative · BiotechnologySEC FORM 4 Code A—229,775 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—118,625 at $0.00filing
11 Jun 2026filed 15 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$164K626 at $261.20filing
8 Jun 2026filed 10 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$389K1,444 at $269.33filing
8 Jun 2026filed 10 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$11K40 at $270.55filing
8 Jun 2026filed 10 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$389K1,444 at $269.33filing
8 Jun 2026filed 10 Jun 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Sold$11K40 at $270.55filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—168,922 at $0.00filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—78,624 at $0.00filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—168,922 at $0.00filing
6 Mar 2026filed 10 Mar 2026ONC BeOne MedicinesBiotechnologySEC FORM 4 Code A—78,624 at $0.00filing

News

Contrasting PainReform (NASDAQ:PRFX) & BeOne Medicines (NASDAQ:ONC)ONC · tickerreport.com · 21 Oct 2026

0 headlines in the last 90 days name Xiaobin Wu; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care53

Buys in green, sells in red, by the company’s sector.

Related people

Xiaodong WangDirector and Other role · Director and Other at BeOne Medicines, filing Form 4 there in the last year
Chan Henry LeeSVP, General Counsel · SVP, General Counsel at BeOne Medicines, filing Form 4 there in the last year
BAKER BROS. ADVISORS LPDirector and 10% owner · Director at BeOne Medicines, filing Form 4 there in the last year
Titus B. BallPrincipal Accounting Officer · Principal Accounting Officer at BeOne Medicines, filing Form 4 there in the last year
John OylerChief Executive Officer · Chief Executive Officer at BeOne Medicines, filing Form 4 there in the last year
Aaron RosenbergChief Financial Officer · Also traded ONC in the last 90 days